Sponsor:
Brigham and Women's Hospital
Code:
NCT05730816
Conditions
Mesothelioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Magnesium sulfate
Normal Saline
Brief summary:
Conditions
Mesothelioma
Study ID
NCT05730816
Start date
Apr 4, 2023
Status verified date
Nov, 2025
Completion date
Jan 1, 2028
Anticipated
Primary completion date
Apr 3, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
130 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Magnesium Sulfate
placebo comparator: Normal Saline
Interventions
Magnesium sulfate
Normal Saline
Primary outcome measure
Central contacts
Locations
Brigham and Women's Hospital
Recruiting
Boston, Massachusetts, United States, 02130
Contacts
Shruti Gupta
sgupta21@bwh.harvard.eduDavid E. Leaf
deleaf@bwh.harvard.eduSponsor
Brigham and Women's Hospital
Last update posted
Nov 21, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2025-11-21.